Orchestrates a social science research workflow from literature review through data collection, text analysis, statistical modeling, and report generation. Use when conducting empirical social science research, policy analysis, or mixed-methods studies. NOT for pure natural science analysis or cl...
OpenClawData & Analytics
Infers dynamic gene regulatory networks from bulk time-series expression data using Granger causality (statsmodels), dynGENIE3 (Extra-Trees on ODE-derived expression derivatives), and dynamic Bayesian networks (bnlearn). Identifies time-delayed regulatory relationships and tracks network rewiring...
ClaudeCodexOpenClawData & Analytics
End-to-end clinical trial analysis workflow from CDISC SDTM/ADaM loading through ICH E9(R1) estimand-driven primary analysis to CONSORT 2025 regulatory-compliant reporting. Covers data preparation, FDA 2023 marginal vs conditional logistic regression, categorical tests with Boschloo, modern HTE/s...
ClaudeCodexOpenClawData & Analytics
Tests associations between categorical variables in clinical data using chi-square, Fisher's exact, Boschloo, Cochran-Mantel-Haenszel, and modern McNemar variants with calibrated confidence intervals (Wilson, Newcombe, Miettinen-Nurminen). Use when analyzing categorical outcomes, paired binary en...
ClaudeCodexOpenClawData & Analytics
Performs logistic regression for clinical trial outcomes (binary, ordinal, multinomial) with marginal-vs-conditional estimand reporting per FDA 2023 covariate adjustment guidance, g-computation/standardisation for marginal effects, modified Poisson for RR, Brant test for proportional odds, Firth ...
ClaudeCodexOpenClawData & Analytics
Treats a ctDNA assay as a molecule-counting experiment at the Poisson edge and builds its analytical-validation case the measurement-science way. Covers the genome-equivalent currency (~330 haploid copies/ng), the lambda = input_GE x VAF sampling ceiling (lambda>=3 for ~95% detection), the error-...
ClaudeCodexOpenClawData & Analytics
Tests individual CpG sites for differential methylation (DMC/DMP) from bisulfite sequencing counts or array/continuous beta-value matrices. Covers the count-vs-continuous fork that dictates the model, beta-value vs M-value logit (Du 2010), beta-binomial overdispersion count models (DSS, methylKit...
ClaudeCodexOpenClawData & Analytics
End-to-end time-course analysis from expression matrix to temporal patterns and enrichment. Covers temporal DE, Mfuzz soft clustering, optional rhythm detection, GAM trajectory fitting, and per-cluster pathway enrichment. Use when analyzing bulk time-series expression experiments from any omics p...
ClaudeCodexOpenClawData & Analytics
Performs subgroup and heterogeneous treatment effect (HTE) analyses for clinical trials. Covers Mantel-Haenszel pooling, Breslow-Day, interaction tests in regression, RERI for additive interaction, modern data-adaptive HTE methods (STEPP, SIDES, causal forests, X/R-learners), Bayesian shrinkage (...
ClaudeCodexOpenClawData & Analytics
Medical biostatistics hypothesis testing toolkit: t-tests, ANOVA, chi-square, Fisher exact, Mann-Whitney, Kruskal-Wallis, sample size calculation, power analysis, multiple testing correction, survival analysis, and clinical trial biostatistics.
ClaudeCodexOpenClawData & Analytics
Computes and interprets treatment effect measures (OR, RR, RD, HR, NNT) with calibrated confidence intervals (Wilson, Newcombe, Miettinen-Nurminen, MOVER, profile likelihood, Bender NNT) and reports marginal vs conditional estimands per FDA 2023 covariate adjustment guidance. Use when reporting t...
ClaudeCodexOpenClawData & Analytics
Computes sample size and power for clinical trials including continuous, binary, and time-to-event endpoints; superiority, non-inferiority, and equivalence designs; FDA 2016 non-inferiority margin selection with M1/M2 framework; Schoenfeld 1981 and Lakatos 1988 for survival; Schuirmann TOST and 8...
ClaudeCodexOpenClawData & Analytics